Companies: 10,795·Total market cap: $144.5T

Liminal BioSciences Inc.

Liminal BioSciences Inc.

LMNLNASDAQHealthcare

$8.50

+$0.01(+0.12%)

Market Cap$27621005

P/E Ratio—

52W High$8.5

52W Low$3.1

Avg Volume24K

Open$8.48

Beta1.03

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Liminal BioSciences Inc.（LMNL）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · LMNL · 截至 Jun 9, 2026

关键指标

EPS (TTM)$4.18Earnings history

PE Ratio (TTM)2.0×PE Ratio deep dive

Revenue (TTM)492000.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding84,600Shares outstanding history

Next EarningsTBAEarnings history

探索 Liminal BioSciences Inc. 数据

分析师预测$— · Hold

股息不分红

营收$401000-37.64%

盈利EPS $-341.80+35.83%

财务快照

FY 2022Revenue$401000.00▼ 37.64% YoY

202020212022

FY 2022Net Income-$28.9M▲ +35.83% YoY

202020212022

FY 2022EPS$-341.80▲ +35.83% YoY

202020212022

TTM:Revenue: $492000.00Net Income: $354000.00EPS: $4.18View income statement →

分析师评级与目标价

Hold2 位分析师

Strong Buy

0

Buy

0

Hold

2

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$8.50Current

$—Avg Target

$—High

合计: 2 · 买入占比: 0.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Liminal BioSciences Inc.

$8.50+0.12%$27.6M #2

$0.33+0.22%$29.7M #3

Angion Biomedica Corp.

$1.00+0.00%$30.1M #4

AnPac Bio-Medical Science Co., Ltd.

$4.30-3.15%$27.0M #5

Freeline Therapeutics Holdings plc

$6.49+0.15%$28.3M #6

Opus Genetics, Inc.

$4.03+0.00%$328.0M

股票表现

1D+0.00%

1W+0.00%

1M+0.00%

3M+1.67%

YTD+157.58%

1Y+67.32%

5Y-99.77%

关于 Liminal BioSciences Inc.

CEOBruce Pritchard BA, CA, FIOD

IPO DateDec 18, 2009

Employees251

CountryCA

Websiteliminalbiosciences.com

Liminal BioSciences Inc. operates as a clinical-stage biopharmaceutical firm, primarily engaged in creating innovative small molecule drug therapies. The company concentrates on addressing inflammator…

Biotechnology HealthcareNASDAQCA

关于股票概览与关键数据

Liminal BioSciences Inc.（LMNL）是 Biotechnology 行业的 Healthcare 类公司，于 Dec 18, 2009 在 NASDAQ 上市。截至最近交易日，LMNL 股价为 $8.50，市值约为 $27.6M。过去12个月累计回报 +67.32%，年初至今回报 +157.58%。

根据 2 位华尔街分析师，Liminal BioSciences Inc. 股票共识评级为Hold，12个月平均目标价为 $—。2022 财年 Liminal BioSciences Inc. 营收 $401000.00，净利润 -$28.9M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Liminal BioSciences Inc.（LMNL）股价为 $8.50，在 NASDAQ 上市，52周区间为 $3.10 – $8.50。

LMNL 最新股价LMNL quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议